Alize Pharma SAS
8Patents
6Active
8Granted
40Portfolio score
Filing activity: Dec 18, 2002 → Dec 14, 2012 · 5 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7485620B2 | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof | Human Necessities | 17 | Expired |
| US7666833B2 | Pharmaceutical compositions comprising unacylated ghrelin and therapeutical uses thereof | Human Necessities | 10 | Active |
| US7825090B2 | Use of ghrelin and unacylated ghrelin compositions for treating insulin resistance | Human Necessities | 6 | Expired |
| US8318664B2 | Unacylated ghrelin fragments as therapeutic agent in the treatment of obesity | Chemistry; Metallurgy | 2 | Active |
| US8476408B2 | Unacylated ghrelin and analogs as therapeutic agents for vascular remodeling in diabetic patients and treatment of cardiovascular disease | Human Necessities | 1 | Active |
| US8222217B2 | Unacylated ghrelin as therapeutic agent in the treatment of metabolic disorders | Human Necessities | 1 | Active |
| US8071368B2 | Methods for promoting growth and survival of insulin-secreting cells | Human Necessities | 1 | Active |
| US9550821B2 | Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.